Insider Trading & Ownership of Alan W. Dunton

Location
King Of Prussia, PA
Summary
The estimated net worth of Alan W. Dunton is at least $824,668 dollars as of 27 Jan 2026. Alan W. Dunton is the Director of CorMedix Inc. and owns shares of CorMedix Inc. (CRMD) stock worth about $822.3K. Alan W. Dunton is the Director of PALATIN TECHNOLOGIES INC and owns shares of PALATIN TECHNOLOGIES INC (PTNT) stock worth about $2.4K.
Signature
/s/ Beth Zelnick Kaufman, attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Alan W. Dunton and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Alan W. Dunton has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $824,668.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: CorMedix Inc. ($822,275).
  • Past-year value change for that position: -$391,300.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Alan W. Dunton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRMD CorMedix Inc. Director $822,275 -$391,300 -32% 26 Jan 2026
PTNT, PTN PALATIN TECHNOLOGIES INC Director $2,393 09 Dec 2025
OGEN ORAGENICS INC Director 11 Dec 2025

Insider Transactions Reported by Alan W. Dunton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .